http://orcid.org/0000-0001-5989-7922
Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Magdalena Meissner, Andrea Napolitano, Khin Thway, Paul Huang & Robin L Jones. (2023) Pharmacotherapeutic strategies for epithelioid sarcoma: are we any closer to a non-surgical cure?. Expert Opinion on Pharmacotherapy 24:12, pages 1395-1401.
Read now
Read now
Helena Nyström, Mats Jönsson, Mef Nilbert & Ana Carneiro. (2023) Immune-cell infiltration in high-grade soft tissue sarcomas; prognostic implications of tumor-associated macrophages and B-cells. Acta Oncologica 62:1, pages 33-39.
Read now
Read now
Maria A Smolle, Laurin Herbsthofer, Mark Goda, Barbara Granegger, Iva Brcic, Marko Bergovec, Susanne Scheipl, Barbara Prietl, Amin El-Heliebi, Martin Pichler, Armin Gerger, Florian Posch, Martina Tomberger, Pablo López-García, Julia Feichtinger, Claudia Baumgartner, Andreas Leithner, Bernadette Liegl-Atzwanger & Joanna Szkandera. (2021) Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma. OncoImmunology 10:1.
Read now
Read now
Jay S. Wunder, Minji J. Lee, Junghyun Nam, Beatrice Y. Lau, Brendan C. Dickson, Dushanthi Pinnaduwage, Shelley B. Bull, Peter C. Ferguson, Andrew Seto, Nalan Gokgoz & Irene L. Andrulis. (2020) Osteosarcoma and soft-tissue sarcomas with an immune infiltrate express PD-L1: relation to clinical outcome and Th1 pathway activation. OncoImmunology 9:1.
Read now
Read now
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now
Read now
Wenli Zuo & Lingdi Zhao. (2019) Recent advances and application of PD-1 blockade in sarcoma. OncoTargets and Therapy 12, pages 6887-6896.
Read now
Read now
Sebastian Klein, Oana-Diana Persa, Cornelia Mauch, Ka-Won Noh, Roberto Pappesch, Svenja Wagener-Ryczek, Reinhard Buettner, Alexander Quaas & Doris Helbig. (2019) First report on two cases of pleomorphic dermal sarcoma successfully treated with immune checkpoint inhibitors. OncoImmunology 8:12.
Read now
Read now
Articles from other publishers (56)
Enar Jumaniyazova, Anastasiya Lokhonina, Dzhuliia Dzhalilova, Anna Kosyreva & Timur Fatkhudinov. (2023) Immune Cells in the Tumor Microenvironment of Soft Tissue Sarcomas. Cancers 15:24, pages 5760.
Crossref
Crossref
Huali Ye, Minxun Lu, Chongqi Tu & Li Min. (2023) Necroptosis in the sarcoma immune microenvironment: From biology to therapy. International Immunopharmacology 122, pages 110603.
Crossref
Crossref
Chin Sern Yiong, Tzu Ping Lin, Vivian Yujing Lim, Tan Boon Toh & Valerie Shiwen Yang. (2023) Biomarkers for immune checkpoint inhibition in sarcomas – are we close to clinical implementation?. Biomarker Research 11:1.
Crossref
Crossref
Ashutosh Mishra, Anurag Singh, Madhu Kumar, Mala Sagar, Malti Kumari, Sumaira Qayoom & Vijay Kumar. (2023) Expression of PD-L1 in Malignant Soft Tissue Neoplasm and Their Correlation with Clinicopathological Parameters. Journal of Laboratory Physicians.
Crossref
Crossref
Sylvia M. Cruz, Cyrus J. Sholevar, Sean J. Judge, Morgan A. Darrow, Khurshid R. Iranpur, Lauren E. Farley, Marshall Lammers, Aryana M. Razmara, Cordelia Dunai, Alicia A. Gingrich, Julia Persky, Hidetoshi Mori, Steven W. Thorpe, Arta M. Monjazeb, William J. Murphy & Robert J. Canter. (2023) Intratumoral NKp46+ natural killer cells are spatially distanced from T and MHC-I+ cells with prognostic implications in soft tissue sarcoma. Frontiers in Immunology 14.
Crossref
Crossref
Sho Watanabe, Tatsunori Shimoi, Tadaaki Nishikawa, Asuka Kawachi, Hitomi Sumiyoshi Okuma, Momoko Tokura, Shu Yazaki, Chiharu Mizoguchi, Motoko Arakaki, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Yuki Kojima, Kazuki Sudo, Emi Noguchi, Akihiko Yoshida, Akira Kawai, Yasuhiro Fujiwara & Kan Yonemori. (2023) Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy. Scientific Reports 13:1.
Crossref
Crossref
Leilei Li, Wenhui Yang, Daqi Jia, Shiqi Zheng, Yuzhe Gao & Guanghui Wang. (2023) Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation. Breast Cancer 30:4, pages 666-684.
Crossref
Crossref
Kai Yu, Lan Wang, Fan Bu, Jingxuan Zhang, Yubin Hai, Rui Hu, Ji Lu & Xiaoju Shi. (2023) Retroperitoneal undifferentiated pleomorphic sarcoma with total nephrectomy: a case report and literature review. Frontiers in Surgery 10.
Crossref
Crossref
Shin Ishihara, Takeshi Iwasaki, Kenichi Kohashi, Kengo Kawaguchi, Yu Toda, Toshifumi Fujiwara, Nokitaka Setsu, Makoto Endo, Yoshihiro Matsumoto, Yasuharu Nakashima & Yoshinao Oda. (2022) Clinical significance of signal regulatory protein alpha and T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif domain expression in undifferentiated pleomorphic sarcoma. Journal of Cancer Research and Clinical Oncology 149:6, pages 2425-2436.
Crossref
Crossref
Valentina Evdokimova, Hendrik Gassmann, Laszlo Radvanyi & Stefan E. G. Burdach. (2022) Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma. Cancers 15:1, pages 272.
Crossref
Crossref
Stefan G. van Ravensteijn, Yvonne M. H. Versleijen-Jonkers, Melissa H. S. Hillebrandt-Roeffen, Marije E. Weidema, Maikel J. L. Nederkoorn, Kalijn F. Bol, Mark A. J. Gorris, Kiek Verrijp, Leonie I. Kroeze, Tessa J. J. de Bitter, Richarda M. de Voer, Uta E. Flucke & Ingrid M. E. Desar. (2022) Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups. Cancers 14:23, pages 5938.
Crossref
Crossref
Atsushi Yamashita, Yoshiyuki Suehara, Takuo Hayashi, Tatsuya Takagi, Daisuke Kubota, Keita Sasa, Nobuhiko Hasegawa, Muneaki Ishijima, Takashi Yao & Tsuyoshi Saito. (2022) Molecular and clinicopathological analysis revealed an immuno-checkpoint inhibitor as a potential therapeutic target in a subset of high-grade myxofibrosarcoma. Virchows Archiv 481:4, pages 1-17.
Crossref
Crossref
Kazuhiko Hashimoto, Shunji NishimuraYu ShinyashikiTomohiko ItoHiroki TanakaKazuhiro OhtaniRyosuke KakinokiMasao Akagi. (2022) PD-1, PD-L1, NY-ESO-1, and MAGE-A4 expression in cutaneous angiosarcoma: A case report. Medicine 101:28, pages e29621.
Crossref
Crossref
Timothy Kwang Yong Tay, Joe Poh Sheng Yeong, Eileen Xueqin Chen, Xin Xiu Sam, Johnathan Xiande Lim & Jason Yongsheng Chan. (2022) Soft Tissue Leiomyosarcoma With Microsatellite Instability, High Tumor Mutational Burden, and Programmed Death Ligand-1 Expression Showing Pathologic Complete Response to Pembrolizumab: A Case Report. JCO Precision Oncology:6.
Crossref
Crossref
Kazuhiko Hashimoto, Shunji Nishimura, Tomohiko Ito, Ryosuke Kakinoki & Masao Akagi. (2022) Immunohistochemical expression and clinicopathological assessment of PD-1, PD-L1, NY-ESO-1, and MAGE-A4 expression in highly aggressive soft tissue sarcomas. European Journal of Histochemistry 66:2.
Crossref
Crossref
Alexandra C. Istl & Alessandro Gronchi. (2022) Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward. Cancers 14:7, pages 1831.
Crossref
Crossref
T. Tomassen, M. E. Weidema, M. H. S. Hillebrandt-Roeffen, C. van der Horst, I. M. E. Desar, U. E. Flucke & Yvonne M. H. Versleijen-Jonkers. (2022) Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroups. Immunologic Research 70:2, pages 256-268.
Crossref
Crossref
Carine Ngo & Sophie Postel-Vinay. (2022) Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments. Biomedicines 10:3, pages 650.
Crossref
Crossref
Hira Chaudhary & Sandra D’Angelo. (2022) Role of Virus-Directed Therapy in Soft Tissue Sarcoma. Current Treatment Options in Oncology 23:3, pages 404-414.
Crossref
Crossref
William G. J. Kerrison, Alexander T. J. Lee, Khin Thway, Robin L. Jones & Paul H. Huang. (2022) Current Status and Future Directions of Immunotherapies in Soft Tissue Sarcomas. Biomedicines 10:3, pages 573.
Crossref
Crossref
Yifan Zhang, Yi Chen, Andri Papakonstantinou, Panagiotis Tsagkozis, Christina Linder-Stragliotto & Felix Haglund. (2022) Evaluation of PD-L1 Expression in Undifferentiated Pleomorphic Sarcomas, Liposarcomas and Chondrosarcomas. Biomolecules 12:2, pages 292.
Crossref
Crossref
Matthieu Roulleaux Dugage, Elise F. Nassif, Antoine Italiano & Rastislav Bahleda. (2021) Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review. Frontiers in Immunology 12.
Crossref
Crossref
Ottavia Clemente, Alessandro Ottaiano, Giuseppe Di Lorenzo, Alessandra Bracigliano, Sabrina Lamia, Lucia Cannella, Antonio Pizzolorusso, Massimiliano Di Marzo, Mariachiara Santorsola, Annarosaria De Chiara, Flavio Fazioli & Salvatore Tafuto. (2021) Is immunotherapy in the future of therapeutic management of sarcomas?. Journal of Translational Medicine 19:1.
Crossref
Crossref
Christopher R. Cunningham, Leslie Dodd, Magda Esebua & Lester J. Layfield. (2021) PD-L1 expression in sarcomas: An immunohistochemical study and review of the literature. Annals of Diagnostic Pathology 55, pages 151823.
Crossref
Crossref
Maria A. Smolle, Laurin Herbsthofer, Barbara Granegger, Mark Goda, Iva Brcic, Marko Bergovec, Susanne Scheipl, Barbara Prietl, Martin Pichler, Armin Gerger, Christopher Rossmann, Jakob Riedl, Martina Tomberger, Pablo López-García, Amin El-Heliebi, Andreas Leithner, Bernadette Liegl-Atzwanger & Joanna Szkandera. (2021) T-regulatory cells predict clinical outcome in soft tissue sarcoma patients: a clinico-pathological study. British Journal of Cancer 125:5, pages 717-724.
Crossref
Crossref
Siddh van Oost, Debora M. Meijer, Marieke L. Kuijjer, Judith V. M. G. Bovée & Noel F. C. C. de Miranda. (2021) Linking Immunity with Genomics in Sarcomas: Is Genomic Complexity an Immunogenic Trigger?. Biomedicines 9:8, pages 1048.
Crossref
Crossref
Luana Madalena Sousa, Jani Sofia Almeida, Tânia Fortes-Andrade, Manuel Santos-Rosa, Paulo Freitas-Tavares, José Manuel Casanova & Paulo Rodrigues-Santos. (2021) Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy. Cancers 13:15, pages 3885.
Crossref
Crossref
Kazuhiko Hashimoto, Shunji Nishimura, Tomohiko Ito & Masao Akagi. (2021) Characterization of PD-1/PD-L1 immune checkpoint expression in soft tissue sarcomas. European Journal of Histochemistry 65:3.
Crossref
Crossref
Mohamed Kelany, Thomas FE. Barth, Dina Salem & Marwa M. Shakweer. (2021) Prevalence and Prognostic Implications of PD-L1 Expression in Soft Tissue Sarcomas. Pathology and Oncology Research 27.
Crossref
Crossref
Shin Ishihara, Takeshi Iwasaki, Kenichi Kohashi, Yuichi Yamada, Yu Toda, Yoshihiro Ito, Yousuke Susuki, Kengo Kawaguchi, Dai Takamatsu, Shinichiro Kawatoko, Daisuke Kiyozawa, Taro Mori, Izumi Kinoshita, Hidetaka Yamamoto, Toshifumi Fujiwara, Nokitaka Setsu, Makoto Endo, Yoshihiro Matsumoto, Yasuharu Nakashima & Yoshinao Oda. (2021) The association between the expression of PD-L1 and CMTM6 in undifferentiated pleomorphic sarcoma. Journal of Cancer Research and Clinical Oncology 147:7, pages 2003-2011.
Crossref
Crossref
Hongbo Zhang, Yu Xia, Chunqiu Yu, Huijie Du, Jinchang Liu, Hui Li, Shihui Huang, Qihua Zhu, Yungen Xu & Yi Zou. (2021) Discovery of Novel Small-Molecule Inhibitors of PD-1/PD-L1 Interaction via Structural Simplification Strategy. Molecules 26:11, pages 3347.
Crossref
Crossref
Laurene S Cheung, Lingling Chen, Teniola F Oke, Thomas B Schaffer, Karim Boudadi, Jillian T Ngo, John McMahon Gross, Holly Kemberling, Luis A Diaz, Evan Lipson, John-WIlliam Sidhom, Janis Taube, Robert Anders, Drew M Pardoll, Dung T Le, Christian F Meyer & Nicolas Llosa. (2021) Anti-PD-1 elicits regression of undifferentiated pleomorphic sarcomas with UV-mutation signatures. Journal for ImmunoTherapy of Cancer 9:6, pages e002345.
Crossref
Crossref
Jingyuan Fan, Xinyi Qin, Rongquan He, Jie Ma & Qingjun Wei. (2021) Gene expression profiles for an immunoscore model in bone and soft tissue sarcoma. Aging 13:10, pages 13708-13725.
Crossref
Crossref
Larisa LehmerFranchesca ChoiChristina KrausJessica ShiuSebastien de Feraudy & Ashley Elsensohn. (2021) Histopathologic PD-L1 Tumor Expression and Prognostic Significance in Nonmelanoma Skin Cancers: A Systematic Review. The American Journal of Dermatopathology 43:5, pages 321-330.
Crossref
Crossref
Saeed Asiry, Gina Kim, Panagiota S. Filippou, Luis Rivera Sanchez, David Entenberg, Douglas K. Marks, Maja H. Oktay & George S. Karagiannis. (2021) The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Crossref
Agnieszka Zając, Sylwia K. Król, Piotr Rutkowski & Anna M. Czarnecka. (2021) Biological Heterogeneity of Chondrosarcoma: From (Epi) Genetics through Stemness and Deregulated Signaling to Immunophenotype. Cancers 13:6, pages 1317.
Crossref
Crossref
Landa Shi, Yuqiang Wang, Longqing Li, Dean Chou, Yao Zhao, Shuhao Zhang, Limin Wang, Min Zhang & Yilin Liu. (2021) Prognostic value of pretreatment anemia in patients with soft tissue sarcoma. Medicine 100:37, pages e27221.
Crossref
Crossref
Chuan Hu, Bo Chen, Zhangheng Huang, Chuan Liu, Lin Ye, Cailin Wang, Yuexin Tong, Jiaxin Yang & Chengliang Zhao. (2020) Comprehensive profiling of immune-related genes in soft tissue sarcoma patients. Journal of Translational Medicine 18:1.
Crossref
Crossref
Yandong Miao, Jiangtao Wang, Qiutian Li, Wuxia Quan, Yingying Wang, Chen Li, Jingjing Wu & Denghai Mi. (2020) Prognostic value and immunological role of PDCD1 gene in pan-cancer. International Immunopharmacology 89, pages 107080.
Crossref
Crossref
Mayanne M.T. Zhu, Elahe Shenasa & Torsten O. Nielsen. (2020) Sarcomas: Immune biomarker expression and checkpoint inhibitor trials. Cancer Treatment Reviews 91, pages 102115.
Crossref
Crossref
Javier Martín-Broto, David S. Moura & Brian A. Van Tine. (2020) Facts and Hopes in Immunotherapy of Soft-Tissue Sarcomas. Clinical Cancer Research 26:22, pages 5801-5808.
Crossref
Crossref
Kyoungmin Lee, Joon Seon Song, Jeong Eun Kim, Wanlim Kim, Si Yeol Song, Min Hee Lee, Hye Won Chung, Kyung-Ja Cho, Jong-Seok Lee & Jin-Hee Ahn. (2020) The clinical outcomes of undifferentiated pleomorphic sarcoma (UPS): A single-centre experience of two decades with the assessment of PD-L1 expressions. European Journal of Surgical Oncology 46:7, pages 1287-1293.
Crossref
Crossref
Martin F. Orth, Veit Leonhard Buecklein, Eric Kampmann, Marion Subklewe, Elfriede Noessner, Florencia Cidre-Aranaz, Laura Romero-Pérez, Fabienne Sophie Wehweck, Lars Lindner, Rolf Issels, Thomas Kirchner, Annelore Altendorf-Hofmann, Thomas G. P. Grünewald & Thomas Knösel. (2020) A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas. Cancer Immunology, Immunotherapy 69:7, pages 1353-1362.
Crossref
Crossref
Rodolfo Daniel Cervantes-Villagrana, Damaris Albores-García, Alberto Rafael Cervantes-Villagrana & Sara Judit García-Acevez. (2020) Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Feng Wang, Tao Yu, Chengbin Ma, Hongmou Yuan, Haifei Zhang & Zhiyu Zhang. (2020) Prognostic Value of Programmed Cell Death 1 Ligand-1 in Patients With Bone and Soft Tissue Sarcomas: A Systemic and Comprehensive Meta-Analysis Based on 3,680 Patients. Frontiers in Oncology 10.
Crossref
Crossref
Ana Cristina Vargas, Fiona M. Maclean, Loretta Sioson, Dinh Tran, Fiona Bonar, Annabelle Mahar, Alison L. Cheah, Peter Russell, Peter Grimison, Louise Richardson & Anthony J. Gill. (2020) Prevalence of PD-L1 expression in matched recurrent and/or metastatic sarcoma samples and in a range of selected sarcomas subtypes. PLOS ONE 15:4, pages e0222551.
Crossref
Crossref
Emily Z. Keung, Melissa Burgess, Ruth Salazar, Edwin R. Parra, Jaime Rodrigues-Canales, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, Steven Attia, Richard F. Riedel, James Hu, Scott H. Okuno, Dennis A. Priebat, Sujana Movva, Lara E. Davis, Damon R. Reed, Alexandre Reuben, Christina L. Roland, Denise Reinke, Alexander J. Lazar, Wei-Lien Wang, Jennifer A. Wargo & Hussein A. Tawbi. (2020) Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. Clinical Cancer Research 26:6, pages 1258-1266.
Crossref
Crossref
Kenji Nakano & Shunji Takahashi. (2020) Precision Medicine in Soft Tissue Sarcoma Treatment. Cancers 12:1, pages 221.
Crossref
Crossref
Amanda R. Dancsok, Nokitaka Setsu, Dongxia Gao, Jean-Yves Blay, David Thomas, Robert G. Maki, Torsten O. Nielsen & Elizabeth G. Demicco. (2019) Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas. Modern Pathology 32:12, pages 1772-1785.
Crossref
Crossref
A. T. J. Lee, W. Chew, C. P. Wilding, N. Guljar, M. J. Smith, D. C. Strauss, C. Fisher, A. J. Hayes, I. Judson, K. Thway, R. L. Jones & P. H. Huang. (2019) The adequacy of tissue microarrays in the assessment of inter- and intra-tumoural heterogeneity of infiltrating lymphocyte burden in leiomyosarcoma. Scientific Reports 9:1.
Crossref
Crossref
Henry G. Smith, David Mansfield, Victoria Roulstone, Joan N. Kyula-Currie, Martin McLaughlin, Radhika R. Patel, Katharina F. Bergerhoff, James T. Paget, Magnus T. Dillon, Aadil Khan, Alan Melcher, Khin Thway, Kevin J. Harrington & Andrew J. Hayes. (2019) PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma. Clinical Cancer Research 25:11, pages 3443-3454.
Crossref
Crossref
Pichaya Thanindratarn, Dylan C. Dean, Scott D. Nelson, Francis J. Hornicek & Zhenfeng Duan. (2019) Advances in immune checkpoint inhibitors for bone sarcoma therapy. Journal of Bone Oncology 15, pages 100221.
Crossref
Crossref
Fabio Grizzi, Elena Monica Borroni, Dorina Qehajaj, Sanja Stifter, Maurizio Chiriva-Internati & Ferdinando C. M. Cananzi. 2019. Current Treatment of Retroperitoneal Sarcomas. Current Treatment of Retroperitoneal Sarcomas
21
32
.
W. Weichert. (2018) Molekulare Prädiktoren in der ImmunonkologieMolecular predictors in immune oncology. Der Pathologe 39:6, pages 546-555.
Crossref
Crossref
Naoki Oike, Hiroyuki Kawashima, Akira Ogose, Tetsuo Hotta, Hiroshi Hatano, Takashi Ariizumi, Taro Sasaki, Tetsuro Yamagishi, Hajime Umezu & Naoto Endo. (2018) Prognostic impact of the tumor immune microenvironment in synovial sarcoma. Cancer Science 109:10, pages 3043-3054.
Crossref
Crossref
Jirong (Betty) Mass & Geoffrey Talmon. (2018) Undifferentiated Pleomorphic Sarcoma of Liver: Case Report and Review of the Literature. Case Reports in Pathology 2018, pages 1-5.
Crossref
Crossref